Novel combination of sorafenib and biochanin-A synergistically enhances the anti-proliferative and pro-apoptotic effects on hepatocellular carcinoma cells-Reference-Cited by-同舟云学术

Novel combination of sorafenib and biochanin-A synergistically enhances the anti-proliferative and pro-apoptotic effects on hepatocellular carcinoma cells

Published:2016-07-29 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Youssef Mohieldin M.,Tolba Mai F.,Badawy Noha N.,Liu Andrew W.,El-Ahwany Eman,Khalifa Amani E.,Zada Suher,Abdel-Naim Ashraf B.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep30717.pdf

Reference53 articles.

1. Gomaa, A. I., Khan, S. A., Toledano, M. B., Waked, I. & Taylor-Robinson, S. D. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J. Gastroenterol. 14, 4300–4308 (2008).

2. Cunningham, S. C. et al. Management of early hepatocellular carcinoma in patients with well-compensated cirrlosis. Ann. Surg. Oncol. 16, 1820–1831 (2009).

3. El-Serag, H. B. Hepatocellular carcinoma. N. Engl. J. Med. 365, 1118–1127 (2011).

4. Jaeck, D., Bachellier, P., Oussoultzoglou, E., Weber, J. C. & Wolf, P. Surgical resection of hepatocellular carcinoma. Postoperative outcome and long-term results in Europe: An overview. Liver Transpl. 10, S58–S63 (2004).

5. Llovet, J. M. et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359, 378–390 (2008).

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined neurokinin-1 receptor antagonist and sorafenib is a promising approach for hepatocellular carcinoma therapy;Egyptian Liver Journal;2024-07-12

2. Potential Antitumor Activity of Combined Lycopene and Sorafenib against Solid Ehrlich Carcinoma via Targeting Autophagy and Apoptosis and Suppressing Proliferation;Pharmaceuticals;2024-04-19

3. Liver cancer wars: plant-derived polyphenols strike back;Medical Oncology;2024-04-16

4. Investigation of the effects of Theranekron and Sorafenib treatments on carcinogenesis, apoptosis and biochemical profile in hepatocellular carcinoma in rats;Toxicology Mechanisms and Methods;2024-04-05

5. QbD-driven RP-HPLC method for novel chemo-herbal combination, in-silico, force degradation studies, and characterization of dual drug-loaded polymeric and lipidic nanocarriers;Future Journal of Pharmaceutical Sciences;2023-11-29